Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Diabetologia

• Publication date

  1996-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s001250050594PMID 8960822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Up-Regulated Expression of Plasminogen Activator Inhibitor-1 in Hep G2 Cells: Interrelationship between Insulin and Insulin-Like Growth Factor 1

  1995cited by this paper
• High D-glucose stimulates the cell cycle from the G1 to the S and M phases, but has no competent effect on the G0 phase, in vascular smooth muscle cells.

  1995cited by this paper
• Effects of insulin and some vasoconstrictors on the synthesis and release of t-PA and PAI-1 from cultured human umbilical vein endothelial cells

  1995cited by this paper
• Up-regulation of PAI-1 Synthesis by Insulin and Proinsulin in HEP G2 Cells but not in Endothelial Cells

  1995cited by this paper
• Insulin-specific activation of S6 kinase and its desensitization in cultured rat vascular smooth muscle cells.

  1995cited by this paper
• Plasminogen Activator Inhibitor-1 Expression in Human Liver and Healthy or Atherosclerotic Vessel Walls

  1994cited by this paper
• Differential Regulation of Glucose Transport and Transporters by Glucose in Vascular Endothelial and Smooth Muscle Cells

  1993cited by this paper
• Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis.

  1993cited by this paper
• George Lyman Duff Memorial Lecture. Atherogenesis in diabetes.

  1992cited by this paper
• Stimulation by Proinsulin of Expression of Plasminogen Activator Inhibitor Type-I in Endothelial Cells

  1992cited by this paper
• No Evidence for Short-Term Regulation of Plasminogen Activator Inhibitor Activity by Insulin in Man

  1992cited by this paper
• Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.

  1992cited by this paper
• Increased Expression of Tissue Plasminogen Activator and Its Inhibitor and Reduced Fibrinolytic Potential of Human Endothelial Cells Cultured in Elevated Glucose

  1992cited by this paper
• Pathogenesis of NIDDM: A Balanced Overview

  1992cited by this paper
• Atherogenesis in diabetes

  1992cited by this paper
• Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: Implications for vascular disease in hyperinsulinemic states

  1991cited by this paper
• The Acute Effect of Insulin on Tissue Plasminogen Activator and Plasminogen Activator Inhibitor in Man

  1991cited by this paper
• Expression of genes related to the extracellular matrix in human endothelial cells. Differential modulation by elevated glucose concentrations, phorbol esters, and cAMP.

  1991cited by this paper
• Evolving natural history of coronary artery disease in diabetes mellitus.

  1991cited by this paper
• Basal Expression and Insulin-mediated Induction of PAI-1 mRNA in Hep G2 Cells

  1991cited by this paper
• Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

  1991cited by this paper
• Induction and Possible Role of Fibrinolysis in Diabetes Mellitus

  1991cited by this paper
• Insulin and atheroma. 20-yr perspective.

  1990cited by this paper
• Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery.

  1990cited by this paper
• 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.

  1990cited by this paper
• Plasminogen Activator Inhibitor 1: Biosynthesis and mRNA Level Are Increased by Insulin in Cultured Human Hepatocytes

  1989cited by this paper
• Increased Plasminogen Activator Inhibitor Activity in Non Insulin Dependent Diabetic Patients – Relationship with Plasma Insulin

  1989cited by this paper
• Tissue‐Type Plasminogen Activator Antigen and Plasminogen Activator Inhibitor in Diabetes Mellitus

  1988cited by this paper
• Insulin Stimulates the Synthesis of Plasminogen Activator Inhibitor 1 by the Human Hepatocellular Cell Line Hep G2

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• The pathogenesis of atherosclerosis--an update.

  1986cited by this paper
• Enhancement by interleukin-1 (IL-1) of plasminogen activator inhibitor (PA-I) activity in cultured human endothelial cells.

  1986cited by this paper
• Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects.

  1986cited by this paper
• Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women.

  1986cited by this paper
• A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation

  1986cited by this paper
• Further Studies on the Mechanism of Action of Human Plasma in Stimulating Prostacyclin Production by Rat Smooth Muscle Cells

  1985cited by this paper
• Effect of insulin on growth of cultured human arterial smooth muscle cells

  1981cited by this paper
• Effects of Glucose and Sorbitol on Proliferation of Cultured Human Skin Fibroblasts and Arterial Smooth-muscle Cells

  1978cited by this paper

• Impact of Stress Hyperglycemia Ratio on Adverse Outcomes in Patients With Chronic Thromboembolic Pulmonary Hypertension

  2025cites this paper
• Association of post-thrombotic syndrome with metabolic syndrome and inflammation - a systematic review

  2025cites this paper
• Thrombotic complications following bariatric surgery: how medical tourism poses challenges to comprehensive care in obesity medicine

  2024cites this paper
• Stress hyperglycemia is associated with early neurologic deterioration in patients with acute ischemic stroke after intravenous thrombolysis without hemorrhagic transformation

  2024cites this paper
• From waste to wonder: exploring the hypoglycemic and anti-oxidant properties of corn processing by−products

  2024cites this paper
• Associations between epigenetic aging and diabetes mellitus in a Swedish longitudinal study

  2024cites this paper
• Association of Admission Glucose and Outcomes After Endovascular Treatment for Acute Stroke: Data From the ANGEL-ACT Registry

  2023cites this paper
• Stress hyperglycemia as a modifiable predictor of futile recanalization in patients undergoing mechanical thrombectomy for acute ischemic stroke

  2023cites this paper
• Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes

  2023cites this paper
• A review of stress-induced hyperglycaemia in the context of acute ischaemic stroke: Definition, underlying mechanisms, and the status of insulin therapy

  2023cites this paper
• Taking another look at the management of obesity

  2023cites this paper
• DVT as the Initial Presentation of Multiple Myeloma: A Rare Case Report and Literature Review

  2023cites this paper
• Diabetes- versus smoking-related thrombo-inflammation in peripheral artery disease

  2023cites this paper
• Impact of Stress Hyperglycemia on Early Neurological Deterioration in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis

  2022cites this paper
• Plasminogen Activator Inhibitor-1 in poorly controlled vs well controlled Type-2 Diabetes Mellitus patients: A case-control study in a district hospital in Ghana

  2021cites this paper
• A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease

  2021cites this paper
• Can laser therapy modify the secretion of the tissue-type plasminogen activator and its inhibitor in an endothelial cell culture under hyperglycemia?

  2021cites this paper
• Association of baseline hemoglobin A1c levels with bleeding in patients with non-ST-segment elevation acute coronary syndrome underwent percutaneous coronary intervention: insights of a multicenter cohort study from China

  2020cites this paper
• The hematologic consequences of obesity

  2020cites this paper
• Insulin Resistance and Portal Vein Thrombosis

  2018cites this paper
• New insights into the role of adipose tissue in thrombosis

  2017cites this paper
• Coronary Artery Disease Bradykinin Stimulates the Release of Tissue Plasminogen Activator in Human Coronary Circulation : Effects of Angiotensin-Converting Enzyme Inhibitors

  2016cites this paper
• Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies

  2016cites this paper
• Diabetes Mellitus and Cardiovascular Risk : epidemiology, etiology and intervention

  2016cites this paper
• Acute effects of hyperinsulinemia and hyperglycemia on vascular inflammatory biomarkers and endothelial function in overweight and obese humans.

  2015cites this paper
• Dysfunction of annexin A2 contributes to hyperglycaemia-induced loss of human endothelial cell surface fibrinolytic activity

  2013cites this paper
• Impairment of calcium ATPases by high glucose and potential pharmacological protection

  2013cites this paper
• Insulin clearance is associated with carotid artery intima-media thickness.

  2013cites this paper
• PAI-1 and Diabetes: A Journey From the Bench to the Bedside

  2012cites this paper
• Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?

  2011cites this paper
• Hyperglycemia: a prothrombotic factor?

  2010cites this paper
• Studies on the Role of Vitronectin and Plasminogen-Activator Inhibitor-1 Complexes Beyond Inhibiting Proteases: Binding to the Extracellular Matrix, Cell Interactions and Pathogenesis

  2010cites this paper
• CORRELATION BETWEEN COMPONENT OF METABOLIC SYNDROME WITH PLASMINOGEN ACTIVATOR INHIBITOR-1

  2009cites this paper
• Contribution of insulin resistance to vascular dysfunction

  2009cites this paper
• Insulin-induced impairment via peroxynitrite production of endothelium-dependent relaxation and sarco/endoplasmic reticulum Ca(2+)-ATPase function in aortas from diabetic rats.

  2007cites this paper
• Transgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization.

  2007cites this paper
• Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications

  2007cites this paper
• Elevated Glucose Inhibits Vasoconstriction

  2007cites this paper
• Hyperglycemia in Acute Ischemic Stroke: A Vascular Perspective

  2007cites this paper
• Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type1 diabetic patients

  2007cites this paper
• Hyperinsulinemia, Hyperglycemia, and Impaired Hemostasis

  2007cites this paper
• [Wine, fibrinolysis and health].

  2006cites this paper
• Elevated Glucose Inhibits Vasoconstriction but not Mannitol Following Balloon Angioplasty

  2006cites this paper
• The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management.

  2006cites this paper
• Vino, fibrinolisis y salud

  2006cites this paper
• Obesity Is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes

  2006cites this paper
• Progression of Plasminogen Activator Inhibitor-1 and Fibrinogen Levels in Relation to Incident Type 2 Diabetes

  2006cites this paper
• Modulation of Adipose Tissue Development by Pharmacological Inhibition of PAI-1

  2006cites this paper
• Alterations in Thrombosis and Fibrinolysis in the Metabolic Syndrome

  2005cites this paper
• Variation in the gene for muscle-specific AMP deaminase is associated with insulin clearance, a highly heritable trait.

  2005cites this paper
• Diabetes and Thrombosis

  2005cites this paper
• Selective Insulin Resistance Affecting Nitric Oxide Release But Not Plasminogen Activator Inhibitor-1 Synthesis in Fibroblasts From Insulin-Resistant Individuals

  2005cites this paper
• Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke.

  2005cites this paper
• Platelet function, coagulopathy, and impaired fibrinolysis in diabetes.

  2004cites this paper
• Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk

  2004cites this paper
• Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic linkages.

  2004cites this paper
• Night-time restricted feeding normalises clock genes and Pai-1 gene expression in the db/db mouse liver

  2004cites this paper
• Fibrinolysis, inflammation and cardiovascular disease; Epidemiological studies on Plasminogen activator inhibitor-type 1 and C-reactive protein

  2003cites this paper
• Recent advances in understanding endogenous fibrinolysis: implications for molecular-based treatment of vascular disorders

  2002cites this paper
• Insulin resistance syndrome : clustering of thrombotic risk factors Insulin Resistance Syndrome

  2002cites this paper
• Glucose upregulates plasminogen activator inhibitor-1 gene expression in vascular smooth muscle cells.

  2002cites this paper
• Plasminogen Activator Inhibitor‐1: Physiologic Role, Regulation, and the Influence of Common Pharmacologic Agents

  2002cites this paper
• Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

  2002cites this paper
• Insulin resistance syndrome: interaction with coagulation and fibrinolysis.

  2002cites this paper
• Insulin Causes Endothelial Dysfunction in Humans: Sites and Mechanisms

  2002cites this paper
• Obesity, haemostasis and the fibrinolytic system

  2002cites this paper
• The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm

  2002cites this paper
• Plasminogen Activator Inhibitor Type 1 Is Increased in the Arterial Wall of Type II Diabetic Subjects

  2001cites this paper
• Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors.

  2001cites this paper
• Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat

  2001cites this paper
• Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas

  2001cites this paper
• 重症救急患者におけるtissue factor pathway inhibitor (TFPI) 値の検討

  2001cites this paper
• Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

  2000cites this paper
• Diabetes mellitus induces decreased plasma fibrinolytic activity and increased tissue synthesis of plasminogen activator inhibitor-1 (PAI-1) in the rat

  2000cites this paper
• Plasminogen-activator inhibitor type 1 and coronary artery disease.

  2000cites this paper
• Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy

  1999cites this paper
• A Randomised, Controlled Study of the Effects of Aerobic Exercise and Dietary Fish on Coagulation and Fibrinolytic Factors in Type 2 Diabetics

  1999cites this paper
• Gender Differences in the Relation between Fibrinogen, Tissue-type Plasminogen Activator Antigen and Markers of Insulin Resistance: Effects of Smoking

  1999cites this paper
• PAI-1, Obesity, and Insulin Resistance

  1999cites this paper
• Gender differences in the relation between fibrinogen, tissue-type plasminogen activator antigen and markers of insulin resistance: effects of smoking. D.E.S.I.R. Study Group. Data from an Epidemiological Study on Insulin Resistance Syndrome.

  1999cites this paper
• Contribution of factor VII, fibrinogen and fibrinolytic components to the risk of ischaemic cardiovascular disease: their genetic determinants

  1998cites this paper
• Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells

  1998cites this paper
• Insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells

  1998cites this paper
• Effect of troglitazone on fibrinolysis and activated coagulation in patients with non-insulin-dependent diabetes mellitus.

  1998cites this paper
• Decrease in urokinase-type plasminogen activator (u-PA) levels in patients with non-insulin dependent diabetes mellitus

  1997cites this paper